- Home
- UCL vs BRNS Comparison
UCL vs BRNS Comparison
Compare UCL & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UCL
- BRNS
- Stock Information
- Founded
- UCL 2014
- BRNS 2016
- Country
- UCL Hong Kong
- BRNS United Kingdom
- Employees
- UCL N/A
- BRNS N/A
- Industry
- UCL Telecommunications Equipment
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- UCL Consumer Discretionary
- BRNS Health Care
- Exchange
- UCL Nasdaq
- BRNS Nasdaq
- Market Cap
- UCL 48.7M
- BRNS 41.0M
- IPO Year
- UCL 2020
- BRNS 2021
- Fundamental
- Price
- UCL $2.13
- BRNS $1.11
- Analyst Decision
- UCL
- BRNS Strong Buy
- Analyst Count
- UCL 0
- BRNS 2
- Target Price
- UCL N/A
- BRNS $4.00
- AVG Volume (30 Days)
- UCL 378.8K
- BRNS 64.8K
- Earning Date
- UCL 11-26-2024
- BRNS 11-06-2024
- Dividend Yield
- UCL N/A
- BRNS N/A
- EPS Growth
- UCL 169.91
- BRNS N/A
- EPS
- UCL 0.11
- BRNS N/A
- Revenue
- UCL $87,405,000.00
- BRNS $14,969,000.00
- Revenue This Year
- UCL $11.23
- BRNS $1,805.74
- Revenue Next Year
- UCL $27.52
- BRNS N/A
- P/E Ratio
- UCL $18.91
- BRNS N/A
- Revenue Growth
- UCL 4.73
- BRNS 106.21
- 52 Week Low
- UCL $0.97
- BRNS $0.80
- 52 Week High
- UCL $3.30
- BRNS $4.16
- Technical
- Relative Strength Index (RSI)
- UCL 62.21
- BRNS 54.91
- Support Level
- UCL $1.41
- BRNS $0.98
- Resistance Level
- UCL $3.30
- BRNS $1.25
- Average True Range (ATR)
- UCL 0.39
- BRNS 0.14
- MACD
- UCL 0.11
- BRNS 0.03
- Stochastic Oscillator
- UCL 45.33
- BRNS 68.82
About UCL uCloudlink Group Inc.
Ucloudlink Group Inc provides mobile data connectivity and portable WiFi services. The business operates under uCloudlink 1.0, which focuses on cross-border travelers that need mobile data connectivity services across different countries. Under uCloudlink 2.0, provides mobile data connectivity services to local users across different MNOs in a single country. It generates revenue from the provision of data connectivity services, and the sales of terminals and sales of data related products.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic that guide the immune system to overcome chronic infectious diseases, autoimmunity and cancer.